Kamada (KMDA) Other financing activities (2012 - 2026)
Kamada's (KMDA) quarterly Other financing activities came in at -$467000.0 in Q1 2026, down 43.69% YoY from -$829371.6 in Q1 2025, and down 100.62% on a QoQ basis from $75.5 million in Q4 2025.
Kamada (KMDA) Other financing activities (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 14 years of Other financing activities data on file, last reported at -$467000.0 in Q1 2026.
- Quarterly Other financing activities fell 43.69% year-over-year to -$467000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $70.5 million (down 1.14% YoY) and the FY2025 annual result came in at -$5.9 million, down 107.51% from the prior year.
- Other financing activities eased to -$467000.0 in Q1 2026, from $75.5 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $78.4 million in Q4 2024 to a low of -$11.5 million in Q3 2023.
- A 5-year average of $10.1 million and a median of -$1.5 million in 2022 frame the typical range for Other financing activities.
- The widest YoY moves for Other financing activities: up 3794.62% in 2023, down 1311188.48% in 2023.
- Tracing KMDA's Other financing activities over 5 years: stood at -$1.5 million in 2022, then soared by 3794.62% to $55.6 million in 2023, then jumped by 40.97% to $78.4 million in 2024, then slipped by 3.78% to $75.5 million in 2025, then tumbled by 100.62% to -$467000.0 in 2026.
- The last three Other financing activities figures came in at -$467000.0 (Q1 2026), $75.5 million (Q4 2025), and -$339000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - |
| 10 | Kamada | 462.32 Mn | 432.85 Mn | 22.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -467,000.00 |
| Mar 31, 2026 | -467,000.00 |
| Dec 31, 2025 | 75.47 Mn |
| Dec 31, 2025 | 75.47 Mn |
| Sep 30, 2025 | -339,000.00 |
| Sep 30, 2025 | -339,000.00 |
| Jun 30, 2025 | -4.18 Mn |
| Jun 30, 2025 | -4.18 Mn |
| Mar 31, 2025 | -325,000.00 |
| Mar 31, 2025 | -325,000.00 |
| Dec 31, 2024 | 78.44 Mn |
| Dec 31, 2024 | 78.44 Mn |
| Sep 30, 2024 | -4.47 Mn |
| Sep 30, 2024 | -4.47 Mn |
| Jun 30, 2024 | -2.35 Mn |
| Jun 30, 2024 | -2.35 Mn |
| Mar 31, 2024 | -5.50 Mn |
| Mar 31, 2024 | -5.50 Mn |
| Dec 31, 2023 | 55.64 Mn |
| Dec 31, 2023 | 55.64 Mn |